Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The effect of lncRNA PART1 knockdown on mature miRNA levels in HCC1806 and HCC1395 cells

ABSTRACT: PART1 was knocked down down using GapmeRs specific to PART1. The breast cancer cells used in this study were confirmed to have PART1 expression by qPCR and knockdown of PART was confirmed by qPCR.

ORGANISM(S): synthetic construct Homo sapiens

PROVIDER: GSE163569 | GEO | 2021/02/28

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

The effect of lncRNA PART1 knockdown on gene expression in HCC1806 and HCC1395 cells

Project description:PART1 was knocked down down using GapmeRs specific to PART1. The breast cancer cells used in this study were confirmed to have PART1 expression by qPCR and knockdown of PART was confirmed by qPCR.

2021-02-28 | GSE156114 | GEO

The effect of lncRNA PART1 knockdown on mature miRNA levels in HCC1806 and HCC1395 cells

Project description:The effect of lncRNA PART1 knockdown on mature miRNA levels in HCC1806 and HCC1395 cells

| PRJNA686782 | ENA

RNA sequencing of PART1 knockdown by siRNA in ovarian cancer cells

Project description:The expression of lncRNA PART1 was found to be significantly upregulated in platinum-sensitive patients with ovarian cancer, and this upregulation was positively correlated with a favorable prognosis. Cellular experiments demonstrated that inhibition of PART1 led to cellular senescence and increased resistance to cisplatin and PARP inhibitors. Thus, LncRNA PART1 is a novel target for overcoming resistance to PARP inhibitors in ovarian cancer.

2024-02-01 | GSE253450 | GEO

Next Generation Sequencing Facilitates Quantitative Analysis of lncRNA PART1 Regulated Transcriptomes

Project description:The goals of this study are to analyze the transcriptome profiling (RNA-seq) after lncRNA PART1 overexpression in MGC-803 cells.

2022-09-09 | GSE137074 | GEO

Cisplatin-inducible death receptor 5 antisense long non-coding RNA modulates cell cycle and proliferation in HeLa cells

Project description:We have performed a transcriptomics study in which we first transfected LNA GapmeRs against DR5-AS lncRNA to silence it in HeLa cells. Total RNA was isolated from control as well as transfected cells and silencing was confirmed by qPCR. Total RNAs were subjected to deep-sequencing to identify differentially expressed mRNAs. We then took advantage of bioinformatic tools to identify which pathways are affected by DR5-AS knock-down.

2021-04-01 | GSE160227 | GEO

The effect of lncRNA PART1 knockdown on gene expression in HCC1806 and HCC1395 cells

Project description:The effect of lncRNA PART1 knockdown on gene expression in HCC1806 and HCC1395 cells

| PRJNA656795 | ENA

PPARγ controls alveolar macrophage identity [part1]

Project description:Tissue-resident macrophages comprise heterogeneous populations with unique functions and distinct gene expression signatures. While it has been established that they mostly originate from embryonic progenitors, the signals inducing a characteristic tissue-specific differentiation program remain unknown. Here we identify PPARγ as the crucial transcription factor determining perinatal alveolar macrophage (AM) development and identity. Development of the fetal monocyte derived AM precursor was largely abrogated in CD11c-Cre/Ppargfl/fl mice. To reveal the underlying changes in gene expression, we performed microarray analysis of sorted WT and KO AM and pre-AM from 3 different timepoints. Part1: d2 and d11 sorts & array

2014-09-28 | GSE60247 | GEO

Proteomic profile of human breast cancer cells expressing normal levels or absent of the long non-coding RNA NORAD.

Project description:We describe here the proteome of the human breast cancer cell line MDA-MB-231 expressing normal levels of the lncRNA NORAD, or after knock-down NORAD with siRNA and LNA gapmers.

2023-08-28 | PXD039920 | Pride

Knockdown of the transcription factor PAX6 by short hairpin RNA in the adenocarcinoma cell line HPAFII reveal changes in gene expression of several cancer relevant genes

Project description:PAX6 is an evolutionary conserved transcription factor important for normal development of the CNS, eye and pancreas. Its role in cancer is however poorly understood as both tumor suppressive- and oncogenic properties have been reported. We generated a pancreatic adenocarcinoma cell line (HPAFII) were PAX6 was knocked down by the use of short hairpin RNA. To generate a control cell line scrambled short hairpin RNA was used. Successful knock down of PAX6 was confirmed by RT-qPCR and Western blot. RNA were harvested from shPAX6, shControl and untransfected HPAFII cells, and used in gene expression microarray to look for differences in gene expression when PAX6 was knocked down.

2020-07-01 | E-MTAB-5416 | biostudies-arrayexpress

PPARÎ³ controls alveolar macrophage identity [part1]

Project description:Tissue-resident macrophages comprise heterogeneous populations with unique functions and distinct gene expression signatures. While it has been established that they mostly originate from embryonic progenitors, the signals inducing a characteristic tissue-specific differentiation program remain unknown. Here we identify PPARÎ³ as the crucial transcription factor determining perinatal alveolar macrophage (AM) development and identity. Development of the fetal monocyte derived AM precursor was largely abrogated in CD11c-Cre/Ppargfl/fl mice. To reveal the underlying changes in gene expression, we performed microarray analysis of sorted WT and KO AM and pre-AM from 3 different timepoints. Part1: d2 and d11 sorts & array pre-AM FACS-sorted from lungs of d2 and mature AM from d11 PPARgfl/fl (WT) and CD11c-cre/PPARgfl/fl (KO) mice and subsequently processed for RNA extraction and hybridization on Affymetrix microarrays. 2 biological replicates per group, each composed of pooled cells from 2 individual mice

2014-09-28 | E-GEOD-60247 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data